Benedikt Schaefer

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni, H. Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1997 · 481 citations

Medicine, Oncology, Pharmacology +14

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 217 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

EASL Clinical Practice Guidelines on haemochromatosis

Heinz Zoller, Benedikt Schaefer, Annick Vanclooster et al. · Journal of Hepatology · 2022 · 188 citations · Full text

Medicine, Hematology, Internal Medicine +8

Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation

Karim Hamesch, Mattias Mandorfer, Vítor Magno Pereira et al. · Gastroenterology · 2019 · 150 citations · Full text

Medicine, Molecular Genetics, Pathology +15

Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers

Carolin V. Schneider, Karim Hamesch, Mattias Mandorfer et al. · Gastroenterology · 2020 · 98 citations · Full text

Medicine, Genetics, Molecular Genetics +17